APA (7th ed.) Citation

Kevin P. Cunningham, Kevin P. Cunningham, Lucie H. Clapp, Alistair Mathie, Alistair Mathie, & Emma L. Veale. (2021). The Prostacyclin Analogue, Treprostinil, Used in the Treatment of Pulmonary Arterial Hypertension, is a Potent Antagonist of TREK-1 and TREK-2 Potassium Channels. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Kevin P. Cunningham, Kevin P. Cunningham, Lucie H. Clapp, Alistair Mathie, Alistair Mathie, and Emma L. Veale. The Prostacyclin Analogue, Treprostinil, Used in the Treatment of Pulmonary Arterial Hypertension, Is a Potent Antagonist of TREK-1 and TREK-2 Potassium Channels. Frontiers Media S.A., 2021.

MLA (9th ed.) Citation

Kevin P. Cunningham, et al. The Prostacyclin Analogue, Treprostinil, Used in the Treatment of Pulmonary Arterial Hypertension, Is a Potent Antagonist of TREK-1 and TREK-2 Potassium Channels. Frontiers Media S.A., 2021.